This HTML5 document contains 61 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q65475424
rdf:type
wikibase:Item
schema:description
clinical trial клінічне випробування ensayu clínicu klinisch onderzoek
rdfs:label
Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
skos:prefLabel
Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
schema:name
Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
p:P1476
wds:Q65475424-520EDB01-0DD3-42BC-B838-4548EF896ABA
wdt:P1476
A Phase II Study of Epratuzumab, Rituximab (ER)-CHOP for Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
p:P582
wds:Q65475424-5BFD62D5-1134-467F-B7BC-05457DFA0C2C
wdt:P582
2008-10-01T00:00:00Z
p:P31
wds:Q65475424-E2A8E659-29DC-4D6E-87AF-89E75C30FC7A
wdt:P31
wd:Q30612
p:P580
wds:Q65475424-1014D33E-DEEC-4F23-B633-36A026776CF4
wdt:P580
2006-01-01T00:00:00Z
p:P17
wds:Q65475424-1529A0EB-5A27-421E-B072-B08E1037D346
wdt:P17
wd:Q30
p:P6153
wds:Q65475424-B30CBC60-FD09-474B-99EF-6DD571EEF6D4 wds:Q65475424-BB95EE07-FE27-476A-8DE1-D2DAA5CF8AAA wds:Q65475424-BC1D3C9C-D99A-49E6-B2FC-C44906415537 wds:Q65475424-CED6BC79-E784-4873-B727-8E70F6ADE05B wds:Q65475424-23885FB0-2A9A-484B-8414-B69A9F00997A wds:Q65475424-505EDA9E-EC2C-4A9B-A861-6BC922749006 wds:Q65475424-873D9A39-2182-45D3-A4C5-BA302235CEDC wds:Q65475424-635745D2-B353-4681-AE01-DFBDC7194725
wdt:P6153
wd:Q770544 wd:Q30269666 wd:Q30269543 wd:Q30270451 wd:Q3145247 wd:Q7654755 wd:Q30280192 wd:Q30281210
p:P4844
wds:Q65475424-08AFC012-C5F1-44FD-A59E-3A73B922AB5F wds:Q65475424-0A8107CA-CFC4-4D8B-849F-3568832B384A wds:Q65475424-05E4EC2D-6FC9-4311-8450-959142109A63 wds:Q65475424-4AAEBAFC-0169-405B-8C7C-8594D6D59171 wds:Q65475424-8AF79535-8A63-4FAF-94E8-CE4CF6488ED5 wds:Q65475424-7F4ECA56-D814-4745-B0A5-CCA6B7FC51B4
wdt:P4844
wd:Q424972 wd:Q3730737 wd:Q18936 wd:Q408524 wd:Q29004943 wd:Q412323
p:P2899
wds:Q65475424-1E41F429-973B-4D2E-B23F-C4A061B4DA80
wdt:P2899
18
p:P1050
wds:Q65475424-9073F262-61A4-4E1C-BA81-2E479F20EB6F
wdt:P1050
wd:Q208414
p:P1132
wds:Q65475424-59E41E20-4A9B-4934-B99B-F042C9B74AA4
wdt:P1132
107
p:P8363
wds:Q65475424-0834186E-BFDD-499B-B23D-71EAA2102E79
wdt:P8363
wd:Q78089383
p:P3098
wds:Q65475424-D01D9AFC-4CF2-4547-9F2F-D156CC3D03EF
wdt:P3098
NCT00301821
p:P6099
wds:Q65475424-6BBC987A-013F-42F8-93DD-F02FE519C28C
wdt:P6099
wd:Q42824440